As of 2024-12-14, the Fair Value of Arcutis Biotherapeutics Inc (ARQT) is -8.35 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 12.69 USD, the upside of Arcutis Biotherapeutics Inc is -165.83%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -42.00 | -135.68 | -206.36 | -311.46 | -262.14 | -191.53 |
| YoY growth | -118.07% | -223.05% | -52.09% | -50.93% | 15.84% | -85.66% |
| Market Cap (mil) | 1,485.24 |
| P/E | |
| Forward P/E |
| EPS | -1.67 |
| Avg earnings growth rate | -85.66% |
| TTM earnings | -195.53 |